Hadland Scott E, Walker Leslie Renee
Division of Adolescent/Young Adult Medicine, Department of Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Kresge Building, 677 Huntington Avenue, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Division of Adolescent Medicine, Seattle Children's Hospital, 4800 Sand Point Way Northeast, Seattle, WA 98105, USA; Department of Pediatrics, University of Washington, 1959 Northeast Pacific Street, Box 356320, Seattle, WA 98195, USA.
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):533-48. doi: 10.1016/j.chc.2016.02.006. Epub 2016 Apr 12.
Like their peers in the general youth population, youth with chronic medical conditions (YCMC) are at risk for substance use, including nonmedical use of prescription medications. However, given dangerous disease-substance interactions, the stakes for detecting and intervening on substance use are perhaps even higher for YCMC. Given the risk for nonadherence with chronic disease management, it is incumbent on primary care providers, specialty providers, and behavioral health specialists to be vigilant in asking about substance use and providing brief counseling and referral to substance use treatment when appropriate.
与普通青年人群中的同龄人一样，患有慢性疾病的青年（YCMC）存在药物使用风险，包括非医疗目的使用处方药。然而，考虑到危险的疾病-药物相互作用，对于YCMC而言，检测和干预药物使用的风险可能更高。鉴于存在慢性病管理不依从的风险，初级保健提供者、专科提供者和行为健康专家有责任保持警惕，询问药物使用情况，并在适当时提供简短咨询和转介至药物使用治疗服务。
